Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial... Tender

Procurement Summary

Country : USA

Summary : Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)

Deadline : 08 Mar 2021

Other Information

Notice Type : Tender

TOT Ref.No.: 34517213

Document Ref. No. : RFA-OD-19-022

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV

Tender Details

Tender are invited for Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)

CFDA Number : 93.077 -- Family Smoking Prevention and Tobacco Control Act Regulatory Research

Cost Sharing or Matching Requirement : No

Estimated Total Program Funding : $1, 000, 000

Closing Date for Applications: Mar 08, 2021

Posted Date : Jul 08, 2019

Description: The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications proposing the innovative analysis of existing (publicly available) nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the FDA CTP. Other publicly available data sets would be considered depending on the analyses to be conducted; however, nationally representative analyses will receive priority. Applications not using nationally representative data sets will need to provide justification why the data set is unique, and the research questions cant be answered from a (publicly available) national representative data set. This FOA encourages the analyses of public use datasets that may inform tobacco regulatory actions in the U.S. The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA`s regulation of the manufacture, distribution, and marketing of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).

Documents

 Tender Notice